Not finding it? Sign in to also search OpenAlex live.
-
Intravenous iron administration in patients with heart failure alters endothelial homeostasis with early release of endothelial microvesicles and subsequent mobilization of endothelial progenitor cell2023 European Heart Journal article Biochemistry, Genetics and Molecular Biology Extracellular vesicles in disease Open access
Sebastian Frederik Mause, Martin Berger, Hong Yin Lim, Felix Jan Vogt, Nikolaus Marx, Vincent Matthias Brandenburg
0citations -
Intravenous iron supplementation in heart failure patients induces temporary endothelial dysfunction with release of endothelial microvesicles2023 Frontiers in Immunology article Biochemistry, Genetics and Molecular Biology Extracellular vesicles in disease Open access
Sebastian Frederik Mause, Martin Berger, Hwee Ying Lim, Felix Jan Vogt, Vincent Matthias Brandenburg
8citations -
Clinical Trial: Predicting Response to Iron Therapy in Patients With Active Inflammatory Bowel Disease Using Hepcidin and Functional Iron Indices: A Multicentre Randomised Trial2026 Alimentary Pharmacology & Therapeutics article Medicine Iron Metabolism and Disorders Open access
Lola J. M. Koppelman, Roberta Loveikyte, Rogier L. Goetgebuer, Sander van der Marel, Annemarie Charlotte de Vries, Gerard D. H. Dijkstra, +2 more
2citations -
Effect of clinically relevant iron oxide nanoparticles on macrophage polarization, tumor growth and tumor microenvironment modulation2026 Journal of Controlled Release article Immunology and Microbiology Immune cells in cancer Open access
Karolin Roemhild, Roman A. Barmin, Seyed Mohammadali Dadfar, Ekaterina Savina, Kim. H. K. Lindelauf, Diana Moeckel, +15 more
2citations -
FC 073REGIONAL EFFICACY AND SAFETY RESULTS OF ROXADUSTAT COMPARED WITH PLACEBO OR DARBEPOETIN ALFA IN NON-DIALYSIS-DEPENDENT (NDD) CHRONIC KIDNEY DISEASE (CKD) PATIENTS WITH ANAEMIA
Nada B. Dimkovic, Ciro Esposito, Jonathan Barratt, Christophe Mariat, Evgeny V. Shutov, Władysław Sułowicz
0citations -
Roxadustat for the treatment of anaemia in chronic kidney disease patients not on dialysis: a Phase 3, randomized, open-label, active-controlled study (DOLOMITES)2021 Nephrology Dialysis Transplantation article Medicine Erythropoietin and Anemia Treatment Open access cited by 1 patent
Jonathan Barratt, Branislav Andrić, Avtandil Tataradze, Michael Schömig, Udaya Valluri, Christophe Mariat
151citations -
The Potential Value of Prehabilitation for Preventing Delirium in Elective Surgery for Aneurysms of the Abdominal Aorta2024 Clinical Interventions in Aging article Medicine Intensive Care Unit Cognitive Disorders Open access
Anne Lise Meulenbroek, Ewout Willem Steyerberg, Ties L. Janssen, Stefanie R. van Mil, Miriam C. Faes, Lijckle van der Laan
5citations -
Multicomponent Prehabilitation as a Novel Strategy for Preventing Delirium in Older Chronic Limb Threatening Ischemia Patients: A Study Protocol2022 Clinical Interventions in Aging article Medicine Intensive Care Unit Cognitive Disorders Open access
Anne Lise Meulenbroek, Miriam C. Faes, Stefanie R. van Mil, Mathijs G. Buimer, Hans GW de Groot, Eelco J. Veen, +10 more
5citations -
A Phase 3, Multicenter, Randomized, Two-Arm, Open-Label Study of Intermittent Oral Dosing of Roxadustat for the Treatment of Anemia in Japanese Erythropoiesis-Stimulating Agent-Naïve Chronic Kidney Disease Patients Not on Dialysis63citations
-
Patient Preferences Study for Treatments of Anemia in CKD Patients Not on Dialysis (NDD)2020 Journal of the American Society of Nephrology conference-abstract Medicine Erythropoietin and Anemia Treatment
Ana Filipa Alexandre, Antonia Morga, Caitlin Thomas, Nicolas Krucien, Tommi Tervonen, Alina Jiletcovici, +1 more
0citations
21 results